All In MedTech

FDA Clearance Tracker · P130008-S021

Inspire II Upper Airway Stimulator

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jun 23, 2017 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jun 23, 2017

Approved

Time to decision

86 days

Received Mar 29, 2017. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P130008-S021
Device name
Inspire II Upper Airway Stimulator
Applicant location
Maple Grove, MN
Received
Mar 29, 2017
Decided
Jun 23, 2017
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P130008

Device type

Device class
Class III

Every decision under product code MNQ

FDA's approval statement

As written in FDA's record.

Approval to expand the Apnea Hypopnea Index (AHI) range from 20 to 65, to 15 to 65 events per hour.

Source documents

Other decisions for Inspire Medical Systems

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

2 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.